| 86 | 0 | 352 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 分析全身免疫炎症指数(SII)对老年射血分数中间值心力衰竭(HFmrEF)患者预后的预测价值。方法 选择2019年11月至2024年4月首都医科大学附属北京潞河医院收治的152例老年HFmrEF患者为研究对象,根据1年随访情况分为预后不良组(44例)与预后良好组(108例)。所有患者入院后检测血小板计数(PLT)、中性粒细胞计数(NEUT)、淋巴细胞计数,并计算SII。分析比较两组一般资料及SII,采用受试者工作特征(ROC)曲线评估SII对老年HFmrEF患者预后的预测价值,采用多因素Logistic回归分析老年HFmrEF患者预后的相关影响因素。结果 预后不良组美国纽约心脏病协会(NYHA)心功能分级及肌酸激酶同工酶、超敏C反应蛋白(hs-CRP)、胱抑素C(Cys C)、N末端B型钠尿肽前体(NT-proBNP)、PLT、NEUT、中性粒细胞/淋巴细胞比值(NLR)、SII水平均高于预后良好组(P<0.05),LC、左心室射血分数(LVEF)低于预后良好组(P<0.05)。ROC曲线分析显示,PLT、NLR及SII预测老年HFmrEF患者预后不良的曲线下面积(95%CI)分别为0.847(0.797~0.897)、0.858(0.808~0.908)、0.902(0.852~0.952),经De-Long检验,SII的预测效能显著优于PLT、NLR(Z=2.341、2.018,均P<0.05)。多因素Logistic回归分析显示,外周血hs-CRP>5.68 mg/L(OR=2.423)、Cys C>1.33 mg/L(OR=1.790)、NT-proBNP>1 286.62 pg/mL(OR=3.404)、SII>1 220.22(OR=2.776)为老年HFmrEF患者预后不良的危险因素(P<0.05)。结论 SII与老年HFmrEF患者预后密切相关,可有效预测患者预后不良发生。
Abstract:Objective To analyze the predictive value of the systemic immune-inflammation index(SII) for the prognosis of elderly patients with heart failure with mid-range ejection fraction(HFmrEF). Methods A total of 152 elderly patients with HFmrEF admitted to Beijing Luhe Hospital, Capital Medical University from November 2019 to April 2024 were selected as the study subjects. Based on the one-year follow-up results, they were divided into a poor prognosis group(n=44) and a good prognosis group(n=108). After admission, all patients underwent measurements of platelet count(PLT), neutrophil count(NEUT), lymphocyte count, and related indicators, and SII was calculated. General data and SII were compared between the two groups. The predictive value of SII for the prognosis of elderly HFmrEF patients was evaluated using receiver operating characteristic(ROC) curve analysis, and multivariate logistic regression was used to analyze factors influencing prognosis. Results The poor prognosis group had higher NYHA cardiac function classification, creatine kinase isoenzyme, high-sensitivity C-reactive protein(hs-CRP), cystatin C(Cys C), N-terminal pro-brain natriuretic peptide(NT-proBNP), PLT, NEUT, neutrophil-to-lymphocyte ratio(NLR), and SII levels compared to the good prognosis group(P<0.05), while LC and left ventricular ejection fraction(LVEF) were lower(P<0.05). ROC curve analysis showed that the areas under the curve(95%CI) of PLT, NLR, and SII for predicting poor prognosis in elderly HFmrEF patients were 0.847(0.797–0.897), 0.858(0.808–0.908), and 0.902(0.852–0.952), respectively. DeLong's test revealed that the predictive efficacy of SII was significantly better than that of PLT and NLR(Z=2.341, 2.018, both P<0.05). Multivariate logistic regression analysis indicated that peripheral blood hs-CRP>5.68 mg/L(OR=2.423), Cys C>1.33 mg/L(OR=1.790), NT-proBNP>1 286.62 pg/mL(OR=3.404), and SII>1 220.22(OR=2.776) were risk factors for poor prognosis in elderly HFmrEF patients(P<0.05). Conclusion SII is closely associated with the prognosis of elderly HFmrEF patients and can effectively predict the occurrence of poor prognosis.
[1] MENTZ R J, WARD J H, HERNANDEZ A F, et al. Rationale, design and baseline characteristics of the PARAGLIDE-HF trial:sacubitril/valsartan vs valsartan in HFmrEF and HFpEF with a worsening heart failure event[J]. J Card Fail, 2023, 29(6):922-930.
[2]李玲. N末端脑钠肽前体在心力衰竭患者预后评估中的价值研究[J].中华灾害救援医学, 2024, 11(8):957-960.
[3]刘海英,战伟,王蒙,等.两种标志物在老年高血压合并射血分数中间值的心力衰竭患者心室重构中的表达[J].中华老年心脑血管病杂志, 2024, 26(7):737-741.
[4] YE C, YUAN L, WU K, et al. Association between systemic immuneinflammation index and chronic obstructive pulmonary disease:a population-based study[J]. BMC Pulm Med, 2023, 23(1):295.
[5]王玲玲.全身免疫炎症指数(SII)与急性胆源性胰腺炎病情严重程度的相关性研究[D].扬州:扬州大学, 2024.
[6]茹炜.全身免疫炎症指数联合预后营养指数对急性Stanford A型主动脉夹层患者术后预后的评估价值[J].转化医学杂志, 2024,13(3):340-343, 349.
[7]中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志, 2018, 46(10):760-789.
[8]林志彬,滕中华,徐艳如,等.全血细胞衍生的炎症标志物及其联合N末端B型利钠肽原对慢性心力衰竭患者预后的预测价值[J].中华心血管病杂志, 2025, 53(2):143-150.
[9]赵静静,高伟勤.免疫/炎症指数在心力衰竭中的研究进展[J].感染、炎症、修复, 2024, 25(4):331-334.
[10]庞茜,慈东岳,杨传华.中西医诊疗射血分数中间值心衰研究进展[J].山东中医杂志, 2023, 42(1):89-95.
[11]李建军,罗长久,文欣,等.沙库巴曲缬沙坦联合伊伐布雷定对老年射血分数保留心力衰竭患者预后的影响[J].中国药物应用与监测, 2025, 22(4):604-608.
[12]祖晓麟,韩福生,金彦彦,等.肌少症对老年射血分数中间值心力衰竭患者心血管事件的影响相关因素分析[J].心肺血管病杂志,2023, 42(7):651-655.
[13]李佩洁,李泽信,游焜,等. NLR、PLR、SII在乙肝相关性肝癌中的表达水平及影响乙肝相关性肝癌预后的因素分析[J].保健医学研究与实践, 2024, 21(2):88-93.
[14]伏玉洁,赵宁军,卓晓英,等.全身免疫炎症指数和全身炎症反应指数与急性缺血性脑卒中病人神经损伤程度及预后的相关性研究[J].安徽医药, 2024, 28(12):2372-2377.
[15]李林玲,王秀榕,刘官智.全身免疫炎症指数与寻常型银屑病患者病情、预后的相关性分析[J].转化医学杂志, 2025, 14(1):169-174.
[16]张忠满,朱轶,陈旭锋,等.全身免疫炎症指数对非ST段抬高型心肌梗死患者早期发生急性心力衰竭的预测价值[J].南京医科大学学报(自然科学版), 2025, 45(3):382-388.
[17]李延民,冯艳,魏燕云,等.心肌梗死溶栓危险指数、全身免疫炎症指数及营养控制状态评分对急性心肌梗死介入治疗预后的预测价值[J].川北医学院学报, 2023, 38(7):906-909.
[18]李红娟,张艳丽,张炜,等.司库奇尤单抗治疗寻常性银屑病临床疗效及血小板参数与病情的相关性研究[J].实用皮肤病学杂志,2025, 18(3):190-194, 198.
[19]任一梦,李冉,王敬敏.妊娠期糖尿病患者血小板、凝血功能及纤溶参数变化的临床价值[J].感染、炎症、修复, 2024, 25(3):222-225.
[20]王平正,张雨,王淑萍.心率变异性联合中性粒细胞计数预测稳定型冠心病患者发生急性心肌梗死的效能及意义[J].中国心血管病研究, 2024, 22(12):1096-1100.
[21]张寒,李军,刘小江,等.中性粒细胞/淋巴细胞比值预测老年高血压性脑出血患者脑水肿及预后的临床价值[J].海军医学杂志,2024, 45(11):1153-1157.
[22]苏鑫洪,郭东斌,沈东炜,等.中性粒细胞/淋巴细胞比值对闭合性重型颅脑损伤预后判断的研究[J].中华神经外科疾病研究杂志,2024, 18(2):55-57.
基本信息:
中图分类号:R541.6
引用信息:
[1]王晓文,李凤杰,蒋志锋,等.全身免疫炎症指数对老年射血分数中间值心力衰竭患者预后的预测价值[J].转化医学杂志,2025,14(10):34-38.
基金信息:
首都医科大学附属北京潞河医院临床研究立项项目(LHYY2025-YJZ027)
2025-10-20
2025-10-20